Urgent Recall of Kids’ Gummies Due to Hidden Drug Ingredient

Parents and caregivers in the United Kingdom are being urged to dispose of a brand of children’s health gummies after regulatory authorities discovered they contain a prescription-only drug. The warning pertains to the **Nutrition Ignition Kids Magnesium Glycinate Gummies**, which were found to include synthetic melatonin, a substance not indicated on the product’s packaging.

Tests conducted by the **Medicines and Healthcare products Regulatory Agency (MHRA)** revealed that each gummy contains between **1.5 and 1.7 mg** of melatonin. This hormone, which helps regulate sleep-wake cycles, is naturally produced by the body. However, its synthetic form is only available via prescription for children over the age of six who suffer from sleep disorders such as insomnia. The recommended starting dose for children is typically **1 mg**.

The presence of synthetic melatonin in these gummies raises significant health concerns. According to the MHRA, the packaging suggests a dosage of one to two gummies per day, which could lead to excessive intake. Side effects from melatonin consumption can include headaches, drowsiness, nausea, and in some cases, hyperactivity or dizziness.

Dr. Alison Cave, the chief safety officer at the MHRA, emphasized the seriousness of the situation. “We advise any parent or caregiver to stop use of this product and safely dispose of it,” she stated. “Anyone who suspects that their child, or a child in their care, is experiencing side effects from this product is advised to cease consumption and consult a healthcare professional. Additionally, they should report any incidents directly to the MHRA Yellow Card scheme.”

While melatonin is often prescribed for its licensed uses, the MHRA has noted that no serious side effects have been observed in clinical studies involving children. Nonetheless, the lack of clear labeling on the **Nutrition Ignition** packaging poses a significant risk. The absence of melatonin information could lead parents to unknowingly administer higher doses than recommended, potentially jeopardizing their children’s health.

As awareness of this issue spreads, parents are encouraged to check their medicine cabinets and ensure that they are not in possession of these gummies. The safety of children remains a priority, and any concerns should be addressed promptly with healthcare professionals.

In conclusion, the **MHRA**’s alert serves as a crucial reminder for vigilance regarding children’s health products. The discovery of unlisted ingredients in popular supplements highlights the importance of regulatory oversight and consumer awareness.